Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Translational Cancer Research|January 9, 2026
Examining the effectiveness of follow-up chemotherapy in large cell neuroendocrine carcinoma: special emphasis on stage T1-2N0M0 according to 9th edition TNM guidelinesHongying Pan, Yin Zhang, Minjie Ying, et al.
International Journal of Cancer|December 29, 2025
Prior immunotherapy enhances survival outcomes of third-line apatinib treatment in advanced gastric cancer: A retrospective cohort studyChongya Zhai, Minjie Ying, Xufei Wang, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 4, 2024
Exploring the Role of Preoperative Systemic Therapy and Primary Resection in NSCLC With Extrathoracic Metastases: Identifying the Optimal CandidatesXuanhong Jin, Xinyu Zhu, Hangchen Shen, et al.
Cancers|January 11, 2024
Multilevel Heterogeneity of Colorectal Cancer Liver MetastasisHao Chen, Chongya Zhai, Xian Xu, et al.
Scientific Reports|February 27, 2024
Exploration and machine learning model development for T2 NSCLC with bronchus infiltration and obstructive pneumonia/atelectasisXuanhong Jin, Yang Pan, Chongya Zhai, et al.
Frontiers in Oncology|March 8, 2021
The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung CancerChongya Zhai, Xiaoling Zhang, Lulu Ren, et al.
Scientific Reports|January 18, 2024
Association of frailty with mortality in cancer survivors: results from NHANES 1999-2018Chongya Zhai, Luxi Yin, Jiaying Shen, et al.
The Journal of International Medical Research|August 21, 2020
NF1 germline mutation in a Chinese family with colon cancerHaizhou Lou, Chongya Zhai, Liu Gong, et al.
Frontiers in Pharmacology|August 20, 2024
Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agentsXuanhong Jin, Yang Pan, Cheng Cheng, et al.
BMC Geriatrics|January 8, 2024
Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic reviewChongya Zhai, Xuanhong Jin, Liangkun You, et al.
Pageof 2